Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists. - Wikidata - awgldk - TriplyDB

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

http://www.wikidata.org/entity/Q37841568

about

The new biology: a bridge to clinical cardiology.Prasugrel is effective and safe for neurointerventional procedures.Advances in the monitoring of anti-P2Y12 therapy.

P2860

Q37082703-BF3E4D7F-D0DF-419A-99C5-FB933CED526F Q38012439-251FDEEF-0904-45A1-B17C-908A1F496004 Q38037121-25D360DB-AEF2-4FAF-9CA5-AC3745E413D8

P2860

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

http://www.wikidata.org/entity/Q37841568

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

@en

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

@nl

type

label

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

@en

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

@nl

prefLabel

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

@en

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

@nl

P1433

Q37841568-27909660-6C9F-4725-9F5A-56A9645D67DC

P1476

Q37841568-FD12E275-94E1-49DE-BF98-C0161C9816C2

P2093

Q37841568-2EA069DB-54BC-42FF-AC5D-EFFA99EEA364

Q37841568-42E7F589-A55E-48A1-A0B1-270E1A9FE1AE

P2860

Q37841568-1E5C3E9F-566C-456B-A78E-A8FE082D92F1

Q37841568-26EC2013-BD6F-4CD8-8211-DD8DC64C0277

Q37841568-2C7AEAC7-5C89-46A0-A16F-14B1B7738992

Q37841568-2CCF8DBA-A2C2-47CE-99A6-BE4665F32593

Q37841568-3FD351CD-103A-4021-A69F-4EC6A7760BE2

Q37841568-45D046BD-1578-48EC-92CD-14108963890E

Q37841568-466AC2AA-CB27-4F7F-8912-0E27EE7A21EA

Q37841568-573CDB59-2CA8-431D-B8F4-705FACF87786

Q37841568-58B92BC7-631F-49E6-AF00-5258CB341400

Q37841568-63817F92-53AF-46F2-921B-7034DDD4C847

P304

Q37841568-142F5E66-F0D4-465D-8001-99ED7CDE3334

P31

Q37841568-843DF68E-EA72-4F34-9858-FBCE0C5E4BF5

P356

Q37841568-3AC67450-527F-4243-A60E-CD31CBFDA2C7

P433

Q37841568-4D1F8D88-82A4-47FA-B03D-500F4DE47E82

P478

Q37841568-B207C9B0-8A17-4CEE-BE30-DCD8E963592A

P577

Q37841568-F139A96C-045C-4F67-A671-ADE8C5C98E31

P698

Q37841568-EAD003ED-06D2-495F-9DB1-51A59EB0F5FA

P356

P1433

Biomarkers in Medicine

P1476

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

@en

P2093

Colin M Barker

http://www.w3.org/2001/XMLSchema#string

Matthew J Price

http://www.w3.org/2001/XMLSchema#string

P2860

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.

Bedside evaluation of thienopyridine antiplatelet therapy.

ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation.

P304

43-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.11.1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21319964

http://www.w3.org/2001/XMLSchema#string